Andrea Farolfi

Azienda USL di Bologna

Papers

3

Total Citations

10

H-Index

2

About

Andrea Farolfi is a leading researcher at the intersection of urologic oncology and advanced imaging, with a primary focus on prostate cancer (PCa) management. Her work centers on optimizing the clinical utility of Prostate-Specific Membrane Antigen (PSMA)-PET imaging and integrating it with cutting-edge surgical technologies. A major contribution is her investigation into PSMA expression heterogeneity, demonstrating through immunohistochemistry analysis of high-risk prostate biopsies how tumor biology can impact PSMA-PET patient selection—a finding with direct implications for staging accuracy. Farolfi is also pioneering the translation of imaging into the operating room; she has developed and described a novel technique for augmented reality (AR) PSMA-3D guided robotic pelvic lymph node dissection (PLND), enabling surgeons to intraoperatively visualize suspicious lymph node metastases identified on PSMA-PET. Complementing this, she has introduced a free, open-source method for creating patient-specific 3D virtual reality anatomical models from DICOM images, democratizing presurgical planning. Her work, accumulating over 10 citations from these key papers, is establishing new standards for precision surgery and personalized treatment in prostate cancer.

Research Focus

Key Achievements

2
H-Index
3
Papers
10
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Immunohistochemistry analysis of PSMA expression at prostatic biopsy in high-risk prostate cancer: potential implications for PSMA-PET patient selection
6 citations · 2024
📈 Most Prolific Year: 2025 (2 Papers)
🤝 Key Collaborators: 40
🏛 Institutions: Azienda USL di Bologna

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago